Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Rebecca Maxson"'
Autor:
Katie E. Cardone, Rebecca Maxson, Katherine H. Cho, Joseph M. Davis, Wasim S. El Nekidy, Sandra L. Kane-Gill, Anusha McNamara, Lori Wazny, Lana Wong, Marisa Battistella
Publikováno v:
Kidney Medicine, Vol 4, Iss 8, Pp 100509- (2022)
Patients with kidney disease represent a medically complex group of patients with high medication burdens that could benefit from clinical pharmacy services as part of the interdisciplinary care team to optimize medication use. The “Advancing Ameri
Externí odkaz:
https://doaj.org/article/e779857bf0684cf1bb85c66e55fffdd3
Autor:
Joanna Q. Hudson, Rebecca Maxson, Erin F. Barreto, Katherine Cho, Amanda J. Condon, Elizabeth Goswami, Jean Moon, Bruce A. Mueller, Thomas D. Nolin, Heather Nyman, A. Mary Vilay, Calvin J. Meaney
Publikováno v:
Kidney Medicine, Vol 4, Iss 8, Pp 100508- (2022)
Chronic kidney disease is a public health problem that has generated renewed interest due to poor patient outcomes and high cost. The Advancing American Kidney Health initiative aimed to transform kidney care with goals of decreasing the incidence of
Externí odkaz:
https://doaj.org/article/67cddc737fbc4034b4775aef5607d523
Autor:
Rebecca Maxson
Publikováno v:
Physician Assistant Clinics. 8:xvii-xix
Autor:
Deborah L. Pestka, Rebecca Maxson, Shelby Bradley, Yu‐Chia Hsu, Andrew Traynor, Wendy L. St. Peter
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 5:1121-1127
Autor:
Rebecca Maxson, Caroline Jackson
Publikováno v:
Physician Assistant Clinics. 7:215-228
Autor:
Rebecca Maxson
Publikováno v:
Physician Assistant Clinics. 8:i
Publikováno v:
Renal Medicine and Clinical Pharmacy ISBN: 9783030376543
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c725157d092c3f16d731192066d528e
https://doi.org/10.1007/978-3-030-37655-0_5
https://doi.org/10.1007/978-3-030-37655-0_5
Autor:
Rebecca Maxson, Katelin M. Lisenby
Publikováno v:
The Journal for Nurse Practitioners. 14:526-530
Diabetes mellitus (DM) is the leading cause of kidney failure in the United States, and controlling DM slows kidney failure. Thus, treatment of DM with antihyperglycemic medications is vital for patients with kidney disease. However, as kidney functi
Publikováno v:
Renal Failure. 38:1677-1682
Current vancomycin dosing guidelines recommend targeting trough concentrations of 15-20 mg/L in complicated infections to avoid treatment failure and resistance. How to accomplish this in the intermittent hemodialysis (IHD) population has not been ad
Autor:
Rebecca Maxson
Publikováno v:
The Journal for Nurse Practitioners. 13:687-692.e3
The kidneys are important for eliminating most medications from the body. As kidney function decreases, patients are at increased risk for adverse events when medications are dosed inappropriately. Issues surrounding estimating kidney function along